Page 289 - Academic Press Encyclopedia of Physical Science and Technology 3rd BioTechnology
P. 289

P1: GPB/GRB  P2: GLQ Final pages
 Encyclopedia of Physical Science and Technology  EN016J-783  August 1, 2001  10:58






               840                                                                                  Tissue Engineering


               relevant compounds. The surface onto which cells are  testine use cellular aggregates isolated from intestinal
               grown is often shaped according to the final application.  tissue which are seeded onto polymer meshes shaped in a
               For example, bioartificial vascular grafts have been pro-  tubularformandanastomosedtothesmallbowelinanimal
               ducedbyseedingendothelialcellsontotheluminalsurface  models. The aggregates develop and form villus structures
               of small-diameter (6 mm or less) synthetic vascular grafts.  lined with a columnar epithelium reminiscent of the in
                 In cases where the ability to control transport is not  vivo counterpart, and in some areas a subjacent connective
               an important aspect of the function of the bioengineered  tissue containing smooth muscle cells develops. Anas-
               tissues, a simple way to maintain certain epithelial cells  tomosis to the existing bowel and bowel resection in the
               is via seeding in a three-dimensional matrix in a man-  host receiving the implants have significantly improved
               ner similar to that used for connective tissue construction.  morphogenesis and differentiation of the implant.
               For example, hepatocytes can be maintained in porous or
               mesh-type matrices made of a variety of materials includ-
                                                                 C. Endocrine Tissues
               ing polylactic–glycolic copolymer, alginate, etc., wherein
               they have a tendency to aggregate. Such aggregates (some-  Major efforts in this area focus on the development of
               times called organoids) are known to contain cells that  a bioartificial pancreas. Unlike other engineered tissues,
               have maintained their phenotypic stability. However, for  the bioartificial pancreas does not need to physically inte-
               this process to be beneficial, the aggregate size must be  grate with the host’s tissues, as its primary function is to
               controlled to prevent the formation of large aggregates  release insulin in a controlled manner as a function of the
               with anoxic cores.                                patient’s glucose levels. Furthermore, the typical patients
                                                                 needing insulin therapy do not have any functional islet
                                                                 tissue available; therefore, allogeneic or xenogeneic islet
                 3. Epithelial and Connective Tissue Composites
                                                                 sources must be used. For these reasons, the bulk of stud-
               The long-term survival of endothelial and epithelial cells  ies on bioartificial pancreases use islets encapsulated in
               seeded onto artificial polymers is often problematic due  membrane-based devices protecting the islets from the re-
               to inflammatory responses and the poor retention of the  cipient’s immune system. The first devices (dating back
               seeded cells under in vivo conditions. Relevant to the case  to the 1970s) mostly consisted of hollow-fiber bioreactors
               of vascular grafts, it is noteworthy that cultured endothe-  in which islets were placed on the shell side of the biore-
               lial cells rapidly become senescent and die in vitro when  actor, and the patient’s blood flowed through the fibers.
               growth factors are removed from the culture medium.  Although these systems worked well over short periods
               Thus, long-term retention of the cultured endothelium of-  of time, chronically implanted devices tended to activate
               ten requires the continual presence of such factors in the  blood clotting and eventually become clogged. More re-
               implant. A solution to this problem, which also provides  cently, more simple avenues have been explored, such as
               a more intrinsically biocompatible approach to vascular  encapsulating islets in spherical or flat membranes placed
               graft production, is to seed cells on an in vivo-like stromal  in the host’s tissues.
               layer releasing the necessary trophic factors. Similarly,  In theory, allogeneic implants will not trigger immune
               keratinocytes require either growth factors or a mesenchy-  responses as long as the pore size of the capsule is small
               mal “feeder layer” of cells in order to survive and grow.  enoughtopreventimmunecellsfromthehostfromaccess-
                 Some epithelial tissues have by the nature of the  ing the antigens expressed on the implanted cells. How-
               functions performed an extremely complex topology and  ever, antigens shed from the cell surface may trigger a
               organization, which makes it difficult to reproduce  humoral immune response leading to the formation of an-
               faithfully in vitro. For example, the intestine has on one  tibodies. The proteins involved in this type of immune
               side a layer of epithelial cells which selectively transport  rejection include immunoglobins such as IgG and IgM,
               metabolites into the interstitial tissue space, where a  and complement molecules, the largest of which is C1q
               large number of microscopic lymphatic and blood vessels  (mol wt = 410 kD, diameter = 30 nm) which is required
               absorb the transported metabolites. The epithelial layer is  for classical pathway complement-mediated cell damage.
               organized in the form of villi or invaginations to increase  Binding of immunoglobins to cells in the implant without
               the surface area of exchange. Although it may be at  the presence of the complement system would not neces-
               some point possible to reproduce these structures “from  sarily lead to cell damage; therefore, some investigators
               scratch,” it turns out that some of these features can be  have claimed that a membrane with an effective pore size
               generated by the cells themselves if placed in the correct  of less than 30 nm may suffice to protect the encapsulated
               environment, in which case they display an amazing  cells. Smaller membrane pore sizes (<50 kD) have been
               ability to reorganize themselves into functional tissues.  typically used, however. This strategy has shown promise
               Recent efforts in the development of bioengineered neoin-  in animal models, with function remaining after several
   284   285   286   287   288   289   290   291   292   293   294